Why the study?
Is residual myocardial iron following intramyocardial hemorrhage associated with adverse left ventricular remodeling in reperfused STEMI patients?
Is residual myocardial iron following intramyocardial hemorrhage associated with adverse left ventricular remodeling in reperfused STEMI patients?
Residual myocardial iron following intramyocardial hemorrhage in reperfused STEMI patients is associated with adverse LV remodeling, highlighting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Residual iron may identify higher-risk STEMI patients for closer monitoring; leaves open whether iron-targeted interventions alter remodeling.
The majority of ST-segment-elevation myocardial infarction patients with IMH had residual myocardial iron at follow-up. This was associated with persistently elevated T2 values in the surrounding infarct tissue and adverse LV remodeling. IMH and residual myocardial iron may be potential therapeutic targets for preventing adverse LV remodeling in reperfused ST-segment-elevation myocardial infarction patients.
No takes yet. Share an insight, caveat, or question.
Bulluck et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: